Aytu biopharma to participate in the cantor fitzgerald virtual rare orphan disease summit

Englewood, co / accesswire / march 22, 2022 / aytu biopharma, inc. (nasdaq:aytu), a pharmaceutical company focused on developing and commercializing novel therapeutics, today announced that management will participate in a panel discussion titled, "managing clinical trials for rare diseases during & after covid-19," during the cantor fitzgerald virtual rare orphan disease summit on tuesday, march 29, 2022 at 11:00 a.m. et. if you have interest in participating in the cantor fitzgerald virtual rare orphan disease summit, please contact your cantor fitzgerald representative.
AYTU Ratings Summary
AYTU Quant Ranking